INS and type 2 diabetes mellitus: Our findings of improved glycemic control are consistent with earlier studies of T2D patients treated with or without intensive insulin treatment.7–9,19,20 For example, an early study by Vigersky et al. reported significant reductions in HbA1c with intermittent rtCGM use compared with BGM in a cohort of T2D adults treated with basal insulin or noninsulin therapy.9